Pindolol Tablet
Brand names: Pindolol
Category: Cardiovascular
FDA status: To Be Discontinued · Last FDA update: Jan 30, 2026 · First posted: Jan 30, 2026 · 1 manufacturers, 2 listed presentations
As of Jan 30, 2026, the FDA lists Pindolol Tablet as being discontinued. Of 2 manufacturer presentations, 2 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Pindolol, Tablet, 5 mg (NDC 57664-655-88) NDC 57664-655-88 |
Sun Pharmaceutical Industries, Inc. | Not specified | Discontinuation of the manufacture of the drug; Expiry date of last distributed batch January 2027 |
| Pindolol, Tablet, 10 mg (NDC 57664-656-88) NDC 57664-656-88 |
Sun Pharmaceutical Industries, Inc. | Not specified | Discontinuation of the manufacture of the drug; Expiry date of last distributed batch October 2026 |
Related medications in shortage
Other Cardiovascular medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Pindolol Tablet (FDA data as of Jan 30, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Pindolol Tablet. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/pindolol-tablet.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).